Health Care & Life Sciences » Biotechnology | Can-Fite Biopharma Ltd.

Can-Fite Biopharma Ltd. ADR | Ownership

Companies that own Can-Fite Biopharma Ltd. ADR

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Taylor Asset Management, Inc. (Canada)
796,500
3.99%
0
0.21%
06/30/2018
Morgan Stanley & Co. LLC
146,800
0.74%
34,800
0%
06/30/2018
Sabby Capital LLC
109,905
0.55%
-1,118,186
0.07%
06/30/2018
G1 Execution Services LLC
42,227
0.21%
42,227
0%
06/30/2018
Raymond James & Associates, Inc. (Invt Mgmt)
13,700
0.07%
0
0%
06/30/2018
Jane Street Capital LLC
10,090
0.05%
10,090
0%
06/30/2018
Thompson Davis & Co., Inc. (Investment Management)
7,500
0.04%
7,500
0.02%
06/30/2018
AdvisorNet Financial, Inc.
3,400
0.02%
0
0%
06/30/2018
UBS Securities LLC
2,683
0.01%
2,683
0%
06/30/2018
IFP Advisors, Inc.
2,000
0.01%
0
0%
06/30/2018

About Can-Fite Biopharma

View Profile
Address
Kiryat Matalon
Petach Tikva TA 4951778
Israel
Employees -
Website http://www.canfite.com
Updated 07/08/2019
Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.